During the past decade, Heilig Hartziekenhuis Lier conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Heilig Hartziekenhuis Lier" #1 sponsor was "Universitaire Ziekenhuizen KU Leuven" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "ID3 Medical" with 1 trials sponsored and "NHS Lothian" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heilig Hartziekenhuis Lier" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "German Adjuvant Breast Cancer Group" with 1 trials as a collaborator and "Gruppo Oncologico Italiano di Ricerca Clinica" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Heilig Hartziekenhuis Lier" are "Breast Cancer Stage II" (1 trials), "Breast Cancer Stage III" (1 trials), "Hematologic Diseases" (1 trials), "Multiple Myeloma" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Heilig Hartziekenhuis Lier" in a lesser frequency.

Most popular intervention types in "Heilig Hartziekenhuis Lier" are "Drug" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Combination therapy DCB + stent" (1 trials), "Data collection" (1 trials), "Docetaxel / cyclophosphamide" (1 trials), "Gemcitabine" (1 trials) and "Nab-paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heilig Hartziekenhuis Lier" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Heilig Hartziekenhuis Lier". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Heilig Hartziekenhuis Lier, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Heilig Hartziekenhuis Lier, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".